Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Roze AI Wins $12.2 Million South Korea Contracts

Roze AI Wins $12.2 Million South Korea Contracts

MT newswireMT newswire2026/10/06 13:09

09:09 AM EDT, 10/06/2026 (MT Newswires) -- Roze AI (RZAI) said Tuesday its Korean subsidiary won contracts worth about 16.40 billion Korean won ($12.2 million), excluding value-added tax, to deploy its AI-based fire safety technology at three commercial and mixed-use projects in South Korea. The company said the contracts cover two mixed-use developments in Seoul and a new fish market in Incheon. The projects, expected to begin construction in H1 2027, will expand its customer base and commercial presence in South Korea, the company said. It added that the contract values are based on preliminary designs and may change as projects progress.

09:09 AM EDT, 10/06/2026 (MT Newswires) -- Roze AI (RZAI) said Tuesday its Korean subsidiary won contracts worth about 16.40 billion Korean won ($12.2 million), excluding value-added tax, to deploy its AI-based fire safety technology at three commercial and mixed-use projects in South Korea. The company said the contracts cover two mixed-use developments in Seoul and a new fish market in Incheon. The projects, expected to begin construction in H1 2027, will expand its customer base and commercial presence in South Korea, the company said. It added that the contract values are based on preliminary designs and may change as projects progress.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21